Status:
COMPLETED
Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
Lead Sponsor:
Hospital Juarez de Mexico
Conditions:
Obesity
Morbid Obesity
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
Surgical management of Morbid Obesity is increasingly frequent. A low-calorie diet is recommended with the main goal of reducing intrahepatic fat infiltration, fat tissue and making easier the surgery...
Detailed Description
This is a randomized, control trial to investigate the effect and safety of Phentermine in patients with obesity who need a bariatric surgery (BMI \>35 kg/m2 with comorbidities or BMI \> 40 kg/m2). S...
Eligibility Criteria
Inclusion
- Women and men
- \>18 years and \<55 years old.
- Diagnosis of obesity grade II with comorbidities
- Diagnosis of obesity grade III with or without comorbidities
- Approved to bariatric surgery by an interdisciplinary committee
- Having signed the Informed consent form
Exclusion
- Use of addictive substances
- Inability or lack of understanding to achieve lifestyle and behaviour changes
- Mental disease
- Severe Pulmonary disease
- Giant Hiatal hernia, gastric or duodenal ulcer
- Unstable coronary artery disease
- Portal hypertension or esophageal varices
- Surgical or anesthetic high risk
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT03849729
Start Date
March 1 2018
End Date
April 1 2020
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Juárez de México
Mexico City, Mexico City, Mexico, 07760